...
机译:尼宁尼对鼠慢性哮喘模型中气道炎症和重塑的影响
Catholic Univ Korea Dept Internal Med Uijeongbu St Marys Hosp Div Pulm &
Crit Care Med Dept;
Catholic Univ Korea Seoul St Marys Hosp Div Pulm Allergy &
Crit Care Med Dept Internal Med Coll;
Catholic Univ Korea Seoul St Marys Hosp Div Pulm Allergy &
Crit Care Med Dept Internal Med Coll;
Catholic Univ Korea Seoul St Marys Hosp Div Pulm Allergy &
Crit Care Med Dept Internal Med Coll;
Catholic Univ Korea Youido St Marys Hosp Div Pulm Allergy &
Crit Care Med Dept Internal Med Coll;
Catholic Univ Korea Seoul St Marys Hosp Div Pulm Allergy &
Crit Care Med Dept Internal Med Coll;
Catholic Univ Korea Bucheon St Marys Hosp Div Pulm Allergy &
Crit Care Med Dept Internal Med;
Catholic Univ Korea Seoul St Marys Hosp Div Pulm Allergy &
Crit Care Med Dept Internal Med Coll;
Catholic Univ Korea Seoul St Marys Hosp Div Pulm Allergy &
Crit Care Med Dept Internal Med Coll;
chronic asthma; fibroblast growth factor receptor (FGFR); nintedanib; platelet-derived growth factor receptor (PDGFR); vascular endothelial growth factor receptor (VEGFR);
机译:尼宁尼对鼠慢性哮喘模型中气道炎症和重塑的影响
机译:通过调节气道炎症和激活肺成纤维细胞,HMGB 1在慢性哮喘的鼠模型中有助于过敏原诱导的气道重塑
机译:Bu-shen-yi-qi配方通过调节肺中的气道炎症和氧化胁迫来改善尿嘧啶慢性哮喘的呼吸道重塑
机译:LTC4合成酶基因表达对支气管哮喘鼠模型Th2型气道炎症发育的影响
机译:CD200R活化在过敏气道炎症鼠模型中的作用及影响
机译:HMGB1通过调节气道炎症和激活肺成纤维细胞在慢性哮喘的小鼠模型中促进变应原诱导的气道重塑
机译:TRPV1阻断缓解了慢性哮喘鼠模型中的气道炎症和重塑